Almut G. Winterstein, PharmD, PhD

Distinguished Professor, Director For CoDES, Director For Consortium For Medical Marijuana Clinical
Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA, United States

Disclosure information not submitted.

Presentation(s):

• 2E-03 - Patient-Reported Outcome Endpoint Emulation in Heart Failure External Control Study

  Sunday, August 24, 2025
  4:00 PM - 4:15 PM ET

• 3B-05 - Risk of Major Adverse Cardiovascular Events in Patients Receiving Roflumilast for the Treatment of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study Using Target Trial Emulation Framework

  Monday, August 25, 2025
  9:15 AM - 9:30 AM ET

• 3G-03 - Risk of Pregnancy Loss with Vedolizumab Use during Pregnancy Compared to TNF Inhibitors in Individuals with Inflammatory Bowel Disease

  Monday, August 25, 2025
  8:45 AM - 9:00 AM ET

• 3G-05 - Switching to Preferred Antihypertensives during Early Pregnancy in Individuals with Pre-Existing Hypertension and Risk of Pregnancy Loss: Emulating a Target Trial Using Real-World Data

  Monday, August 25, 2025
  9:15 AM - 9:30 AM ET

• 6B-05 - Validation of ICD-10-CM Diagnosis Codes for Low Birth Weight and Small for Gestational Age In Claims Databases

  Tuesday, August 26, 2025
  2:30 PM - 2:45 PM ET